Complete Genomics Aims for Positive Cash Flow by Mid-2010; Position Itself for IPO

During a presentation at the Piper Jaffray Health Care Conference in New York last week, Complete Genomics CEO Cliff Reid also indicated that within three years, the company might provide human genome sequencing services for as little as $3,800 per genome.